165 related articles for article (PubMed ID: 24871342)
1. Many approved drugs have bioactive analogs with different target annotations.
Hu Y; Lounkine E; Bajorath J
AAPS J; 2014 Jul; 16(4):847-59. PubMed ID: 24871342
[TBL] [Abstract][Full Text] [Related]
2. Prediction of off-target drug effects through data fusion.
Yera ER; Cleves AE; Jain AN
Pac Symp Biocomput; 2014; 19():160-71. PubMed ID: 24297543
[TBL] [Abstract][Full Text] [Related]
3. Design of a tripartite network for the prediction of drug targets.
Kunimoto R; Bajorath J
J Comput Aided Mol Des; 2018 Feb; 32(2):321-330. PubMed ID: 29340865
[TBL] [Abstract][Full Text] [Related]
4. Structural and Activity Profile Relationships Between Drug Scaffolds.
Hu Y; Bajorath J
AAPS J; 2015 May; 17(3):609-19. PubMed ID: 25697829
[TBL] [Abstract][Full Text] [Related]
5. Many drugs contain unique scaffolds with varying structural relationships to scaffolds of currently available bioactive compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2014 Apr; 76():427-34. PubMed ID: 24602788
[TBL] [Abstract][Full Text] [Related]
6. Rationalizing structure and target relationships between current drugs.
Hu Y; Bajorath J
AAPS J; 2012 Dec; 14(4):764-71. PubMed ID: 22826035
[TBL] [Abstract][Full Text] [Related]
7. Structure-Promiscuity Relationship Puzzles-Extensively Assayed Analogs with Large Differences in Target Annotations.
Hu Y; Jasial S; Gilberg E; Bajorath J
AAPS J; 2017 May; 19(3):856-864. PubMed ID: 28265982
[TBL] [Abstract][Full Text] [Related]
8. Determining the Degree of Promiscuity of Extensively Assayed Compounds.
Jasial S; Hu Y; Bajorath J
PLoS One; 2016; 11(4):e0153873. PubMed ID: 27082988
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs.
Hu Y; Bajorath J
J Chem Inf Model; 2010 Dec; 50(12):2112-8. PubMed ID: 21070069
[TBL] [Abstract][Full Text] [Related]
10. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
11. DrugBank: a knowledgebase for drugs, drug actions and drug targets.
Wishart DS; Knox C; Guo AC; Cheng D; Shrivastava S; Tzur D; Gautam B; Hassanali M
Nucleic Acids Res; 2008 Jan; 36(Database issue):D901-6. PubMed ID: 18048412
[TBL] [Abstract][Full Text] [Related]
12. GES polypharmacology fingerprints: a novel approach for drug repositioning.
Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
[TBL] [Abstract][Full Text] [Related]
13. Systematic Assessment of Molecular Selectivity at the Level of Targets, Bioactive Compounds, and Structural Analogues.
Hu Y; Bajorath J
ChemMedChem; 2016 Jun; 11(12):1362-70. PubMed ID: 26358784
[TBL] [Abstract][Full Text] [Related]
14. DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies.
Fu C; Jin G; Gao J; Zhu R; Ballesteros-Villagrana E; Wong ST
Bioinformatics; 2013 Jul; 29(14):1834-6. PubMed ID: 23681121
[TBL] [Abstract][Full Text] [Related]
15. DrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rank.
Yuan Q; Gao J; Wu D; Zhang S; Mamitsuka H; Zhu S
Bioinformatics; 2016 Jun; 32(12):i18-i27. PubMed ID: 27307615
[TBL] [Abstract][Full Text] [Related]
16. In silico drug exploration and discovery using DrugBank.
Wishart DS
Curr Protoc Bioinformatics; 2007 Jun; Chapter 14():Unit 14.4. PubMed ID: 18428789
[TBL] [Abstract][Full Text] [Related]
17. Old friends in new guise: repositioning of known drugs with structural bioinformatics.
Haupt VJ; Schroeder M
Brief Bioinform; 2011 Jul; 12(4):312-26. PubMed ID: 21441562
[TBL] [Abstract][Full Text] [Related]
18. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
19. Exploring the associations between drug side-effects and therapeutic indications.
Wang F; Zhang P; Cao N; Hu J; Sorrentino R
J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network.
Daminelli S; Haupt VJ; Reimann M; Schroeder M
Integr Biol (Camb); 2012 Jul; 4(7):778-88. PubMed ID: 22538435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
